+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Differential nuclear staining assay for high-throughput screening to identify cytotoxic compounds



Differential nuclear staining assay for high-throughput screening to identify cytotoxic compounds



Current Cellular Biochemistry 1(1): 1-14



As large quantities of novel synthetic molecules continue to be generated there is a challenge to identify therapeutic agents with cytotoxic activity. Here we introduce a Differential Nuclear Staining (DNS) assay adapted to live-cell imaging for high throughput screening (HTS) that utilizes two fluorescent DNA intercalators, Hoechst 33342 and Propidium iodide (PI). Since Hoechst can readily cross cell membranes to stain DNA of living and dead cells, it was used to label the total number of cells. In contrast, PI only enters cells with compromised plasma membranes, thus selectively labeling dead cells. The DNS assay was successfully validated by utilizing well known cytotoxic agents with fast or slow cytotoxic activities. The assay was found to be suitable for HTS with Z' factors ranging from 0.86 to 0.60 for 96 and 384-well formats, respectively. Furthermore, besides plate-to-plate reproducibility, assay quality performance was evaluated by determining ratios of signal-to-noise and signal-to-background, as well as coefficient of variation, which resulted in adequate values and validated the assay for HTS initiatives. As proof of concept, eighty structurally diverse compounds from a small molecule library were screened in a 96-well plate format using the DNS assay. Using this DNS assay, six hits with cytotoxic properties were identified and all of them were also successfully identified by using the commercially available MTS assay (CellTiter 96® Cell Proliferation Assay). In addition, the DNS and a flow cytometry assay were used to validate the activity of the cytotoxic compounds. The DNS assay was also used to generate dose-response curves and to obtain CC50 values. The results indicate that the DNS assay is reliable and robust and suitable for primary and secondary screens of compounds with potential cytotoxic activity.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 057623464

Download citation: RISBibTeXText

PMID: 27042697


Related references

A High-Throughput Screening Assay to Identify Kidney Toxic Compounds. Current Protocols in Toxicology 69: 9.10.1-9.10.26, 2016

Use of differential scanning fluorimetry as a high-throughput assay to identify nuclear receptor ligands. Nuclear Receptor Signaling 10: E002, 2012

Differential assay for high-throughput screening of antibacterial compounds. Journal of Biomolecular Screening 12(8): 1102-1108, 2007

The use of TrkA-PathHunter assay in high-throughput screening to identify compounds that affect nerve growth factor signaling. Journal of Biomolecular Screening 18(6): 659-669, 2013

Development and Implementation of a High-Throughput High-Content Screening Assay to Identify Inhibitors of Androgen Receptor Nuclear Localization in Castration-Resistant Prostate Cancer Cells. Assay and Drug Development Technologies 14(4): 226-239, 2016

Development of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditions. Bmc Research Notes 9(1): 444, 2016

Development of a Cell-Based High-Throughput Screening Assay to Identify Porcine Host Defense Peptide-Inducing Compounds. Journal of Immunology Research 2018: 5492941, 2018

A high throughput drug screening assay to identify compounds that promote oligodendrocyte differentiation using acutely dissociated and purified oligodendrocyte precursor cells. Bmc Research Notes 9(1): 419, 2016

High-Throughput Screening Using a Whole-Cell Virus Replication Reporter Gene Assay to Identify Inhibitory Compounds against Rift Valley Fever Virus Infection. Journal of Biomolecular Screening 21(4): 354-362, 2016

Development of a homogeneous time-resolved fluorescence assay for high throughput screening to identify Lck inhibitors: comparison with scintillation proximity assay and streptavidin-coated plate assay. Journal of Biomolecular Screening 5(6): 463-470, 2000

High Throughput Screening Assay to Identify Modulators of IL-17 Expression. Combinatorial Chemistry and High Throughput Screening 20(9): 804-819, 2017

A fluorescence-based high-throughput screening assay to identify HIV-1 inhibitors. Methods in Molecular Biology 1030: 3-9, 2013

A high-throughput assay to identify compounds that can induce dimerization of the erythropoietin receptor. Analytical Biochemistry 278(1): 39-45, 2000

High-throughput screening of libraries of compounds to identify CFTR modulators. Methods in Molecular Biology 741: 13-21, 2011

A high-throughput screening assay to identify bacterial antagonists against Fusarium verticillioides. Journal of Basic Microbiology 54(Suppl. 1): S125-S133, 2014